SCHEMBL16258189

SCHEMBL16258189

CCc1nc(C=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1OCC1CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 8/20 0.52
▸ RET P07949 8/20 0.46
▸ ROS1 P08922 8/20 0.46
▸ FLT3 P36888 8/20 0.46
▸ EML4 Q9HC35 8/20 0.46
▸ ALK Q9UM73 8/20 0.46
▸ JAK2 O60674 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ PTK2 Q05397 1/20 0.43
▸ SYK P43405 2/20 0.39
▸ BMPR1B O00238 1/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ CIT O14578 1/20 0.39
▸ AURKA O14965 1/20 0.39
▸ GAK O14976 1/20 0.39
▸ EPHB6 O15197 1/20 0.39
▸ RIPK2 O43353 1/20 0.39
▸ BUB1 O43683 1/20 0.39
▸ SNRNP200 O75643 1/20 0.39
▸ STK16 O75716 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18251069 0.90 EGFR (0.62) EGFRRETROS1FLT3EML4
SCHEMBL16206997 0.90 EGFR (0.63) EGFRRETROS1FLT3EML4
SCHEMBL18251068 0.81 EGFR (0.63) EGFRRETROS1FLT3EML4
SCHEMBL16206915 0.80 EGFR (0.75) EGFRRETROS1FLT3EML4
SCHEMBL16207161 0.79 EGFR (0.79) EGFRRETROS1FLT3EML4
SCHEMBL16206916 0.78 EML4 (0.63) EGFRRETROS1FLT3EML4
SCHEMBL18251070 0.77 EGFR (0.59) EGFRRETROS1FLT3EML4
SCHEMBL16206675 0.77 EGFR (0.80) EGFRRETROS1FLT3EML4
SCHEMBL16206984 0.77 EGFR (0.57) EGFRRETROS1FLT3EML4
SCHEMBL16206774 0.76 EGFR (0.79) EGFRRETROS1FLT3EML4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805940-A1 PYRAZINE CARBOXAMIDE COMPOUND Astellas Pharma Inc. (JP) 2014-11-26 — — EP disclosed
Send feedback